Pattern Computer to present advancements in drug discovery at BIO-Europe 2024

Pattern Computer, Inc. will present at the BIO-Europe 2024 conference in Stockholm from November 4-6. CEO Mark Anderson will discuss advancements in drug discovery, including projects targeting major cancers and the ProSpectral diagnostics platform. The conference will host over 5,500 life sciences professionals and facilitate 29,000 one-on-one meetings. Pattern aims to partner with firms to advance its therapeutic and diagnostic technologies during the event. Pattern's presentation will also cover new AI developments and discoveries made using its Pattern Discovery Engine. The company focuses on solving complex problems in drug discovery and diagnostics.